imetelstat
geron corporation
['imerge trial']
watch: amer zeidan, mbbs, of , discusses topline efficacy findings from the imerge trial of imetelstat in patients with transfusion-dependent lower-risk myelodysplastic syndrome. #asco23 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.